Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Peripheral Artery Disease Market, by Product Type
1.4.2 Europe Peripheral Artery Disease Market, by End User
1.4.3 Europe Peripheral Artery Disease Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter Five Forces Analysis
Chapter 4. Europe Peripheral Artery Disease Market by Product Type
4.1 Europe Drugs Market by Country
4.2 Europe Peripheral Artery Disease Market by Drugs Type
4.2.1 Europe Antiplatelet Medicines Market by Country
4.2.2 Europe Statins Market by Country
4.2.3 Europe Anti Hypertensive Medication Market by Country
4.2.4 Europe Others Market by Country
4.3 Europe Devices Market by Country
4.4 Europe Peripheral Artery Disease Market by Devices Type
4.4.1 Europe Peripheral Stents Market by Country
4.4.2 Europe Peripheral Angioplasty Balloons Market by Country
4.4.3 Europe Peripheral Catheters Market by Country
4.4.4 Europe Plaque Modification Devices Market by Country
4.4.5 Europe Inferior Vena Cava Filters Market by Country
4.4.6 Europe Hemodynamic Flow Alteration Devices Market by Country
4.4.7 Europe Peripheral Accessories Market by Country
Chapter 5. Europe Peripheral Artery Disease Market by End User
5.1 Europe Hospitals Market by Country
5.2 Europe Specialty Clinics Market by Country
Chapter 6. Europe Peripheral Artery Disease Market by Country
6.1 Germany Peripheral Artery Disease Market
6.1.1 Germany Peripheral Artery Disease Market by Product Type
6.1.1.1 Germany Peripheral Artery Disease Market by Drugs Type
6.1.1.2 Germany Peripheral Artery Disease Market by Devices Type
6.1.2 Germany Peripheral Artery Disease Market by End User
6.2 UK Peripheral Artery Disease Market
6.2.1 UK Peripheral Artery Disease Market by Product Type
6.2.1.1 UK Peripheral Artery Disease Market by Drugs Type
6.2.1.2 UK Peripheral Artery Disease Market by Devices Type
6.2.2 UK Peripheral Artery Disease Market by End User
6.3 France Peripheral Artery Disease Market
6.3.1 France Peripheral Artery Disease Market by Product Type
6.3.1.1 France Peripheral Artery Disease Market by Drugs Type
6.3.1.2 France Peripheral Artery Disease Market by Devices Type
6.3.2 France Peripheral Artery Disease Market by End User
6.4 Russia Peripheral Artery Disease Market
6.4.1 Russia Peripheral Artery Disease Market by Product Type
6.4.1.1 Russia Peripheral Artery Disease Market by Drugs Type
6.4.1.2 Russia Peripheral Artery Disease Market by Devices Type
6.4.2 Russia Peripheral Artery Disease Market by End User
6.5 Spain Peripheral Artery Disease Market
6.5.1 Spain Peripheral Artery Disease Market by Product Type
6.5.1.1 Spain Peripheral Artery Disease Market by Drugs Type
6.5.1.2 Spain Peripheral Artery Disease Market by Devices Type
6.5.2 Spain Peripheral Artery Disease Market by End User
6.6 Italy Peripheral Artery Disease Market
6.6.1 Italy Peripheral Artery Disease Market by Product Type
6.6.1.1 Italy Peripheral Artery Disease Market by Drugs Type
6.6.1.2 Italy Peripheral Artery Disease Market by Devices Type
6.6.2 Italy Peripheral Artery Disease Market by End User
6.7 Rest of Europe Peripheral Artery Disease Market
6.7.1 Rest of Europe Peripheral Artery Disease Market by Product Type
6.7.1.1 Rest of Europe Peripheral Artery Disease Market by Drugs Type
6.7.1.2 Rest of Europe Peripheral Artery Disease Market by Devices Type
6.7.2 Rest of Europe Peripheral Artery Disease Market by End User
Chapter 7. Company Profiles
7.1 Becton, Dickinson, and Company
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 SWOT Analysis
7.2 Bayer AG
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expense
7.2.5 SWOT Analysis
7.3 Koninklijke Philips N.V.
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expense
7.3.5 Recent strategies and developments:
7.3.5.1 Acquisition and Mergers:
7.3.6 SWOT Analysis
7.4 Abbott Laboratories
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.4.5 Recent strategies and developments:
7.4.5.1 Acquisition and Mergers:
7.4.6 SWOT Analysis
7.5 Terumo Corporation
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expenses
7.5.5 Recent strategies and developments:
7.5.5.1 Product Launches and Product Expansions:
7.5.6 SWOT Analysis
7.6 B. Braun Melsungen AG
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expenses
7.6.5 SWOT Analysis
7.7 Medtronic PLC
7.7.1 Company overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expenses
7.7.5 Recent strategies and developments:
7.7.5.1 Acquisition and Mergers:
7.7.6 SWOT Analysis
7.8 Boston Scientific Corporation
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expense
7.8.5 Recent strategies and developments:
7.8.5.1 Acquisition and Mergers:
7.8.6 SWOT Analysis
7.9 Cardinal Health, Inc.
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental and Regional Analysis
7.9.4 SWOT Analysis
7.10. Biotronik SE & Co. KG
7.10.1 Company Overview
7.10.2 SWOT Analysis
Unique Offerings 